ListedMainboardEngineeringINDOMIM

Indo-MIM IPO

Indo-MIM IPO is a mainboard IPO raising ₹3,811 Cr at ₹461 – ₹485 a share. It listed on 30 Jul 2026 at ₹700, +44.3% against its issue price of ₹485, and trades at ₹1,014 today (+109.2% since issue). It was subscribed 72× in total.

485
Issue price
1,014
Price now
+109.2%
Since issue price
30 Jul 2026
Listed on
72×Subscribed (final) · all exchanges

72.3 times more demand than shares on offer

populated partly populated we hold nothing here — the tab says why

What this company actually does

Read out of the prospectus’s business section, stripped of its marketing language.

INDO-MIM Limited makes precision engineering components, primarily using metal injection molding (MIM), and also investment casting, precision machining, ceramic injection molding, and metal 3D printing. Their products (triggers, turbocharger vanes, surgical instrument jaws, manifolds, cellphone parts, etc.) are sold to OEM customers in automotive, defence, medical, consumer, and aerospace sectors. They operate 15 factories across India, the US, the UK, and Mexico and exported over 210 million components in FY2026. (FY2026 revenue from operations: ₹41,929.85 million ≈ ₹4,193 crore; 1 crore = 10 million)

How it earns

Direct sales of manufactured precision components to OEM customers across automotive, defence, medical, consumer, and aerospace end-use industries, with 77.20% of FY2026 revenue (₹3,236.97 crore) coming from outside India.

Who buys

Served more than 1,100 customers in FY2026 across 738 unique customer accounts. Customer concentration is low: top 1 customer = 7.97% of revenue (₹334.19 crore), top 3 = 21.65%, top 5 = 28.95%, top 10 = 38.41%. Repeat customers contributed 91.60% of revenue (₹3,840.66 crore). Top 5 customers by FY2026 revenue and their relationship lengths: a defence customer since Fiscal 2010 (17 years), an ECM customer since Fiscal 2024 (3 years), a medical customer since Fiscal 2010 (17 years), an ECM customer since Fiscal 2026 (1 year), and a defence customer since Fiscal 2014 (13 years). Named customers who have given awards: Cummins, Bajaj BAVA, Bosch, Schaeffler, RTX, BHEL, StanleyBlack&Decker, SMP Oil & Gas, Caterpillar, Hero Motors.

Scale

15 manufacturing facilities (6 India, 6 US, 2 UK, 1 Mexico); 4,424 permanent employees in India (4,100 engineers, metallurgists, designers, toolmakers, technicians) plus 497 trainees; 3 sales offices (China, Germany, US) and 13 sales representatives in 9 other countries; over 9,000 types of products manufactured in FY2026; exported over 210 million components in FY2026.

What it says sets it apart

  • Largest global MIM manufacturer with 6.8% market share in CY2025, ranked #1 for the last six consecutive years (F&S Report)
  • World's largest installed MIM manufacturing capacity as of March 31, 2026 (F&S Report), with 15 plants across India (6), US (6), UK (2), and Mexico (1) for dual-shore supply
  • Diversified technology stack spanning MIM, investment casting, precision machining, ceramic injection molding, and metal 3D printing, with over 80 alloying options available as of March 31, 2026
  • Fast new-product introduction: 45-50 new tools produced per month, classified among the fastest in the MIM industry (F&S Report)
  • High level of manufacturing automation: 436 robots and 476 IoT-enabled machines deployed as of March 31, 2026

Revenue mix

Automotive Products Group (APG) 24.61%Defence Products Group (DPG) 18.69%Medical Products Group (MPG) 18.08%Aerospace Products Group 11.96%Consumer Products Group (CPG) 10.8%Others (powder, tools, traded products) 15.86%North America 43.68%Europe 19.97%

The numbers at a glance

The price they’re asking →
44.6×
Earnings multiple (derived)
₹10.87
EPS (stated)
12.7%
PAT margin, FY2026
+26%
Revenue growth, latest year
21.26%
RoNW (stated)
₹58.24
NAV per share (stated)
0.39×
Borrowings / net worth, FY2026

derived: cut-off price Rs485 / stated EPS Rs10.87 (FY26 (year ended March 31, 2026) diluted EPS, restated consolidated). Stated figures are as printed in the prospectus; margins, growth and the borrowing ratio are computed from its own summary table. A multiple is one lens, not a verdict.

The last few years in numbers

From the prospectus’s own summary financial table (restated consolidated). Margins and growth are computed from the stated figures; everything else is as printed.

Revenue
FY20242,870 Cr
FY20253,330 Cr
FY20264,193 Cr
Profit after tax
FY2024284 Cr
FY2025424 Cr
FY2026534 Cr
PeriodRevenueProfit after taxPAT marginNet worthBorrowings
FY20264,193 Cr+26%534 Cr+26%12.7%2,820 Cr1,090 Cr
FY20253,330 Cr+16%424 Cr+49%12.7%2,199 Cr1,247 Cr
FY20242,870 Cr284 Cr9.9%2,051 Cr1,085 Cr

Where the money goes

The offer →
Fresh issue — to the company500 Cr
Offer for sale — to existing holders3,312 Cr

87% of this issue is existing shareholders cashing out — only the fresh issue reaches the business.

How its cohort has done

63 mainboard issues listed in 2026 that we can price today. This is the group this issue belongs to.

+33.9%
Median return since issue price
27%
Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

How the book finished

The category split is the number worth reading, not the total.

QIB204×
Non-institutional51×
Retail6.67×

QIB: 204× their allocation. Retail: 6.67×.

See the full split, sub-category by sub-category →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidQIB, non-institutional and retail, with sub-splits
How demand built over time9 readings held — our own series
Price-point demand curveCumulative bids at each price in the band
Lead managers and registrar5 banks
Official documents5 documents
Listing-day priceOpened at ₹700 on debut
Performance since listingComputed from our own daily closes

What could go wrong

All 13risks & documents →
SevereExports 77-90% of revenue exposed to US tariffsp. 23
SevereTop 10 customers contribute 38-42% of revenuep. 22
SevereMHA approval required under Arms Act for promoter shareholdingp. 48

From the register read out of the issuer’s own prospectus — each item is quoted verbatim with its page on the risks tab.

Led by Axis Capital Limited — median +35.0% across the 112 of its issues we can price. All lead managers →

What happens when

21 JulPre-apply
23 JulBidding opens
27 JulBidding closes
29 JulAllotment
29 JulRefunds
30 JulListing
7 SeptMandate ends

What to watch

  • 87% of the issue is offer for sale — only ₹500 Cr of new money reaches the company.
  • The asking multiple is 44.6× earnings, and the issuer names no listed peers to compare it against.
  • The register's top risk: Exports 77-90% of revenue exposed to US tariffs (prospectus page 23).

Each line restates a disclosure from the prospectus or the exchanges — nothing here is a recommendation to apply to this issue.

Track INDO-MIM LIMITED

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Open the company page

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.